Valuation: Amgen Inc.

Market Cap 240B 362,523B 206B 193B 176B 332B 22,876B 335B 2,273B 885B 11,541B 901B 881B 38,221B P/E 2026 *
28x
P/E 2027 * 25x
Enterprise Value 281B 425,199B 241B 226B 206B 390B 26,831B 393B 2,666B 1,038B 13,537B 1,057B 1,034B 44,829B EV / Sales 2026 *
7.23x
EV / Sales 2027 * 6.86x
Free-Float
99.77%
Yield 2026 *
2.28%
Yield 2027 * 2.41%
1 day+1.72%
1 week+8.77%
Current month+16.93%
1 month+18.33%
3 months+41.01%
6 months+29.45%
Current year+42.11%
1 week 22,570
Extreme 22570
23,790
1 month 19,830
Extreme 19830
23,790
Current year 15,920
Extreme 15920
23,790
1 year 12,320
Extreme 12320
23,790
3 years 6,246.17
Extreme 6246.166666
23,790
5 years 1,280.17
Extreme 1280.166666
23,790
10 years 273.67
Extreme 273.666666
23,790
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Director of Finance/CFO 67 01/01/2020
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Change 5-day change 1-year change 3-year change Capi.($)
+1.72%+8.77% - - 240B
-1.06%+4.27%+73.34%+125.12% 1,111B
+0.53%+4.10%+52.35%+65.45% 658B
+0.48%+6.18%+26.21%+81.27% 467B
+0.92%+4.97%+42.94%+43.69% 369B
+1.25%+4.00%+25.87%+42.82% 301B
+3.02%+7.92%+4.24%+16.06% 256B
-0.36%+5.45%+50.57%+72.33% 240B
+2.86%+5.27%-15.42%-52.34% 207B
+1.38%+7.09%+29.62%+94.90% 182B
Average +1.12%+4.49%+32.19%+54.37% 421.22B
Weighted average by Cap. +0.68%+4.68%+44.12%+73.07%

Financials

2026 *2027 *
Net sales 38.94B 58,829B 33.37B 31.27B 28.56B 53.9B 3,712B 54.43B 369B 144B 1,873B 146B 143B 6,202B 40.2B 60,728B 34.44B 32.27B 29.48B 55.64B 3,832B 56.19B 381B 148B 1,933B 151B 148B 6,403B
Net income 8.6B 12,989B 7.37B 6.9B 6.31B 11.9B 820B 12.02B 81.43B 31.7B 414B 32.28B 31.58B 1,369B 9.39B 14,192B 8.05B 7.54B 6.89B 13B 896B 13.13B 88.97B 34.63B 452B 35.27B 34.5B 1,496B
Net Debt 41.49B 62,677B 35.55B 33.31B 30.43B 57.42B 3,955B 57.99B 393B 153B 1,995B 156B 152B 6,608B 35.83B 54,129B 30.7B 28.77B 26.28B 49.59B 3,416B 50.08B 339B 132B 1,723B 135B 132B 5,707B
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
25/08/26 ARS 23,570.00 -0.51% 1,335
24/08/26 ARS 23,690.00 +1.72% 1,694
21/08/26 ARS 23,290.00 +1.66% 1,465
20/08/26 ARS 22,910.00 -1.76% 1,254
19/08/26 ARS 23,320.00 +4.06% 2,811
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
34
Last Close Price
443.84USD
Average target price
388.48USD
Spread / Average Target
-12.47%

Quarterly revenue - Rate of surprise